blogger delicious digg diigo facebook googleplus linkedin netlog reddit twitter
Skip Navigation LinksJRI > Archive > October-December 2006, Volume 7, Issue 3 > Therapeutic effects of vitamin D and calcium in patients with polycystic ovary syndrome



Volume 7, Issue 3, Number 28 / October-December
(pages 225-233)


Therapeutic effects of vitamin D and calcium in patients with polycystic ovary syndrome




 Corresponding Author
Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Physiology Department Faculty of Medical Sciences, Tarbiyat Modares University, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Biostatistics Department, Faculty of Medicine, Shahed University of Medical Sciences, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran


Related Articles
in Google Scholar in PubMed

 

Other Format
pdfPDF Full Text (En) pdfPDF Full Text (Fa) pdfePUB Full Text (En) pdfPDF Abstract (En) pdfPDF Abstract (Fa) pdf BibTeX pdfRefMan pdfEndNote xmlPMC XML online readerPMC Reader

 


Abstract
Introduction: Polycystic ovary syndrome (PCOS) is the most important cause of oligoovulation and anovulation in women of reproductive age and in infertile women. Considering insulin resistance and hyperinsulinemia in this syndrome, it is believed that calcium, as well as vitamin D, will have a unique role in correcting the impairment in insulin secretion and help the deve-lopment of oocytes in mammals. Therefore, this study was carried out with the objectives of evaluating the effects of calcium on human ovulation and on the size of follicles in comparison with the current use of metformin.Materials & Methods: In this research, all PCOS patients (In accordance with the Rotterdam criteria and diagnosis confirmation by a gynecologist) who attended the infertility unit of Vali-e-Asr Reproductive Health Research Center from 2004 to 2005, after expressing their willingness to participate in the research were assigned to three 20-patient treatment groups as it follows: The cases were treated daily with: 1) Calcium/Vit. D (1000mg), 2) Calcium/Vit. D (1000mg) and metformin (1500mg) or 3) Metformin (1500mg) tablets for 3 months and were followed up for 3 more months. After this 6-month period, the size of dominant follicles, regularity of menses and pregnancy were checked for. After data collection and entry, statistical analysis (Kruskal Wallis, t-test, ANOVA and Generalized Estimating Equation (GEE) Regression) on the basis of the hypothesis, with a significance level of p=0.05 was performed by using SPSS software (Version 11).Results: Considering the response to treatment by the patients (Dominant follicle 12mm in size), GEE showed that the response was significantly higher during the 5th-6th months in the Calcium/Vit. D and metformin treatment group than the ones from the other groups (p= 0.03). Conclusion: Considering the effects of metformin in reducing and regulating insulin production, and vitamin-D in regulating and correcting serum insulin levels, simultaneous administration of these two medications is suggested for the treatment of insulin impairment and reduction of androgen levels for better oocyte maturation.

Keywords: Calcium, Vitamin D, Metformin, Insulin resistance, Hyperandrogenism, Polycystic ovary syndrome


To cite this article:


References
  1. Speroff L, Marc AF. Clinical gynecology endocrinology and infertility. 7th Edition. Lippincott Williams & Wil-kins. 2005;Chapter 12,pp:465
  2. نیرومنش شیرین، رضایی زهرا، افتخار زهرا و همکاران، اصول بیماریهای زنان و زایمان، هکرـ مور، ویرایش سوم، موسسه فرهنگی، انتشاراتی سیمیا، 1378، صفحات:491-489
  3. Jonathan S, Berek. Novak’s Gynecology. Lippincot Williams & Wilkins. 13th Edition. 2002;Chapter27,pp: 996
  4. The Rotterdam ESHRE/ Asrm-sponsored PCOs consen-sus workshop group- revised 2003 consensus on diag-nostic criteria and long term health risks related to polycystic ovary syndrome (PCOs). Human reproduce-tion. 2004;19(1)pp:41-47
  5. Conway GS, Agarwal R, Betteridge DJ, Jacobs HS. Risk factors for coronay syndrome, clininical endocri-nol. 1992;37(2):119-125   [PubMed]
  6. Wild RA. Long-term health consequences of PCOs. Hum reprod update.2002;8(3):231-241   [PubMed]
  7. Tallbot EO, Guzick DS, Sutton-tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20(11):2414-21   [PubMed]
  8. Zborowski JV, Talbtt EO, Cauley JA. Polycystic ovary syndrome, androgen excess, and the impact on bone. Obstet Gynecol Clininical North Am. 2001; 28(1):135-51   [PubMed]
  9. دکتر ملتي. کلسيم و ديابت، مجموعه مقالات پيرامون اختلالات ويتامين D، معاونت پژوهشي دانشگاه علوم پزشکي تهران، مرکز تحقيقات غدد درون ريز متابوليسم دانشگاه علوم پزشکي تهران،مرداد 1381. صفحه:40
  10. Jorde R, Sundsfyord J, Haug E, Bonaa KH. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertention 2000;35: 1154-9   [PubMed]
  11. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149:151-61   [PubMed]
  12. Homa ST, Carroll J, Swann K. The role of calcium in mammalian oocyte maturation and egg activation. Hum Reprod 1993;8:1274-81   [PubMed]
  13. Kaufman M, Homa ST. Defining a role for calcium in the resumption and progression of meiosis in the pig oocyte. J Exp Zool. 1993;265:69-76   [PubMed]
  14. Thys- Yacobs S, Donovan D, Papadopoulos A, Sarrel P,Bilezikian J.P. Vitamin D and Calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999; 64: 430-5   [PubMed]
  15. Toth S, Huneau D, Banrezes B, Ozil JP. Egg activation is the result of calcium signal summation in the Mouse. Reproduction. 2006;131(1):27-34   [PubMed]
  16. Lee JH, Joon SY, Bae IH. Studies on ca+2- channel distribution in maturation arrested mouse oocyte. Mol Reprod Dev. 2004;69(2):174-85   [PubMed]
  17. Zhang HS, Xiao JH, Cao EH, Qin JF. Homocysteine inhibits store- mediated calcium entry in human endothelial cells: evidence for involvement of mem-brance potential and actin cytoskeleton. Mol Cell Biochem. 2005;269(1-2):37-47   [PubMed]
  18. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod. 2003;18(4):721-7   [PubMed]
  19. Chen JC, Wangy L, Liu CP ,Liu Cp , Cheng JS, Chang HT,Yuk-Keung L, et all. Clomiphene, an ovula-tion inducing agent, causes [ca+2] increases in human osteoblast like cells. Chin J Physiol. 2001;44(2):67-72   [PubMed]
  20. Velazquez E, Acosta A, Mendoza SG. Menstural cyc-licity after Metformin therapy in polycystic ovary syndrome. Obstet Gynecol. 1997;90(3):395-5   [PubMed]
  21. Kiatal H, Santuli R, Wright KH, Wallach EE. Exami-nation of the role of calcium in the in vitro perfused ovary with use of ethyleneglycol-bis (beta-amino-ethylether)-n, n'- tetraacetic acid and verapamil. Am J Obstet Gynecol. 1985;152(6 pt 1):705-8   [PubMed]
  22. Kobayashi K, Kiatai H, Santulli R, Wright KH and Wallach EE. Influence of calcium and magnesium deprivation on ovulation and ovum maturation in the perfused rabbit ovary. Biol Reprod 1984;31(2):287-95   [PubMed]
  23. Racowasky C. The releasing action of calcium upon cyclic AMP dependent meiotic arrest in hamster oocytes. J EXP Zool. 1986;239:263-75



Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and copyrighted by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2016 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.